Ethonova
PrivateLast Round
Series A
Mar 1, 2022
Total Funding Raised
$4.26M
Company Overview
Ethonova is a medical device company that develops technologies for the treatment of sepsis and the prevention of cervical cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ethonova Comparables
Compare Ethonova with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rznomics Inc. | 76% | |
| Tempest Therapeutics | 75% | |
| HLB Co., Ltd. | 74% | |
Ethonova Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 1, 2022 | ||||
| Angel | Oct 1, 2020 |
Ethonova Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Albatross Investment | Series A |
| Golden Oak Investment Co., Ltd. | Series A |
| Enlight Ventures | Series A |
| IPS Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2022
$4.26M round led by Albatross Investment.
- Oct 1, 2020
Completed an angel funding round.
Ethonova Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ethonova's valuation, stock price, and market status.